CRP and neoplasm: However future prospective testing will need to incorporate a variety of immunologic predictive biomarkers such as serum lactate dehydrogenase and C reactive protein and tumor PDL-1 status, mutation load, T cell subsets and changes in and presence of tumor infiltrating lymphocytes [15].